Correlation Between Ikena Oncology and Reneo Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ikena Oncology and Reneo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ikena Oncology and Reneo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ikena Oncology and Reneo Pharmaceuticals, you can compare the effects of market volatilities on Ikena Oncology and Reneo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ikena Oncology with a short position of Reneo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ikena Oncology and Reneo Pharmaceuticals.

Diversification Opportunities for Ikena Oncology and Reneo Pharmaceuticals

-0.12
  Correlation Coefficient

Good diversification

The 3 months correlation between Ikena and Reneo is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Ikena Oncology and Reneo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reneo Pharmaceuticals and Ikena Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ikena Oncology are associated (or correlated) with Reneo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reneo Pharmaceuticals has no effect on the direction of Ikena Oncology i.e., Ikena Oncology and Reneo Pharmaceuticals go up and down completely randomly.

Pair Corralation between Ikena Oncology and Reneo Pharmaceuticals

Given the investment horizon of 90 days Ikena Oncology is expected to generate 14.33 times less return on investment than Reneo Pharmaceuticals. But when comparing it to its historical volatility, Ikena Oncology is 1.08 times less risky than Reneo Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Reneo Pharmaceuticals is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  2,880  in Reneo Pharmaceuticals on August 27, 2024 and sell it today you would lose (1,060) from holding Reneo Pharmaceuticals or give up 36.81% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy92.31%
ValuesDaily Returns

Ikena Oncology  vs.  Reneo Pharmaceuticals

 Performance 
       Timeline  
Ikena Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ikena Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Ikena Oncology is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
Reneo Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Good
Over the last 90 days Reneo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very unsteady technical indicators, Reneo Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Ikena Oncology and Reneo Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ikena Oncology and Reneo Pharmaceuticals

The main advantage of trading using opposite Ikena Oncology and Reneo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ikena Oncology position performs unexpectedly, Reneo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reneo Pharmaceuticals will offset losses from the drop in Reneo Pharmaceuticals' long position.
The idea behind Ikena Oncology and Reneo Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA